Cargando…

Heterologous prime-boost with AdC68- and mRNA-based COVID-19 vaccines elicit potent immune responses in mice

Detalles Bibliográficos
Autores principales: Li, Wenjuan, Li, Xingxing, Zhao, Danhua, Liu, Jingjing, Wang, Ling, Li, Miao, Liu, Xinyu, Li, Jia, Wu, Xiaohong, Li, Yuhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666615/
https://www.ncbi.nlm.nih.gov/pubmed/34903732
http://dx.doi.org/10.1038/s41392-021-00843-6
_version_ 1784614247225884672
author Li, Wenjuan
Li, Xingxing
Zhao, Danhua
Liu, Jingjing
Wang, Ling
Li, Miao
Liu, Xinyu
Li, Jia
Wu, Xiaohong
Li, Yuhua
author_facet Li, Wenjuan
Li, Xingxing
Zhao, Danhua
Liu, Jingjing
Wang, Ling
Li, Miao
Liu, Xinyu
Li, Jia
Wu, Xiaohong
Li, Yuhua
author_sort Li, Wenjuan
collection PubMed
description
format Online
Article
Text
id pubmed-8666615
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-86666152021-12-14 Heterologous prime-boost with AdC68- and mRNA-based COVID-19 vaccines elicit potent immune responses in mice Li, Wenjuan Li, Xingxing Zhao, Danhua Liu, Jingjing Wang, Ling Li, Miao Liu, Xinyu Li, Jia Wu, Xiaohong Li, Yuhua Signal Transduct Target Ther Letter Nature Publishing Group UK 2021-12-13 /pmc/articles/PMC8666615/ /pubmed/34903732 http://dx.doi.org/10.1038/s41392-021-00843-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Letter
Li, Wenjuan
Li, Xingxing
Zhao, Danhua
Liu, Jingjing
Wang, Ling
Li, Miao
Liu, Xinyu
Li, Jia
Wu, Xiaohong
Li, Yuhua
Heterologous prime-boost with AdC68- and mRNA-based COVID-19 vaccines elicit potent immune responses in mice
title Heterologous prime-boost with AdC68- and mRNA-based COVID-19 vaccines elicit potent immune responses in mice
title_full Heterologous prime-boost with AdC68- and mRNA-based COVID-19 vaccines elicit potent immune responses in mice
title_fullStr Heterologous prime-boost with AdC68- and mRNA-based COVID-19 vaccines elicit potent immune responses in mice
title_full_unstemmed Heterologous prime-boost with AdC68- and mRNA-based COVID-19 vaccines elicit potent immune responses in mice
title_short Heterologous prime-boost with AdC68- and mRNA-based COVID-19 vaccines elicit potent immune responses in mice
title_sort heterologous prime-boost with adc68- and mrna-based covid-19 vaccines elicit potent immune responses in mice
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666615/
https://www.ncbi.nlm.nih.gov/pubmed/34903732
http://dx.doi.org/10.1038/s41392-021-00843-6
work_keys_str_mv AT liwenjuan heterologousprimeboostwithadc68andmrnabasedcovid19vaccineselicitpotentimmuneresponsesinmice
AT lixingxing heterologousprimeboostwithadc68andmrnabasedcovid19vaccineselicitpotentimmuneresponsesinmice
AT zhaodanhua heterologousprimeboostwithadc68andmrnabasedcovid19vaccineselicitpotentimmuneresponsesinmice
AT liujingjing heterologousprimeboostwithadc68andmrnabasedcovid19vaccineselicitpotentimmuneresponsesinmice
AT wangling heterologousprimeboostwithadc68andmrnabasedcovid19vaccineselicitpotentimmuneresponsesinmice
AT limiao heterologousprimeboostwithadc68andmrnabasedcovid19vaccineselicitpotentimmuneresponsesinmice
AT liuxinyu heterologousprimeboostwithadc68andmrnabasedcovid19vaccineselicitpotentimmuneresponsesinmice
AT lijia heterologousprimeboostwithadc68andmrnabasedcovid19vaccineselicitpotentimmuneresponsesinmice
AT wuxiaohong heterologousprimeboostwithadc68andmrnabasedcovid19vaccineselicitpotentimmuneresponsesinmice
AT liyuhua heterologousprimeboostwithadc68andmrnabasedcovid19vaccineselicitpotentimmuneresponsesinmice